Update on applications of endoscopic cryotherapy in the gastrointestinal tract.

Journal

Current opinion in gastroenterology

ISSN: 1531-7056

Titre abrégé: Curr Opin Gastroenterol

Pays: United States

ID NLM: 8506887

Informations de publication

Date de publication:
25 Apr 2024

Historique:

medline: 25 4 2024

pubmed: 25 4 2024

entrez: 25 4 2024

Statut: aheadofprint

Résumé

Endoscopic cryotherapy has emerged as a minimally invasive procedure for targeted tissue ablation within the gastrointestinal tract. This review aims to provide a comprehensive overview of current clinical applications of EC with a review of the pertinent literature. Endoscopic cryotherapy has demonstrated safety and efficacy for various gastrointestinal conditions. Recent studies have highlighted the efficacy of endoscopic cryotherapy, including both liquid nitrogen-based spray cryotherapy and the novel cryoballoon focal ablation system, in achieving complete eradication of dysplasia and neoplasia in Barrett's esophagus. Endoscopic cryotherapy has also shown promise as a second-line treatment option for patients with dysplastic Barrett's esophagus refractory to radiofrequency ablation and as an alternative to surgical resection for duodenal adenomas, when endoscopic resection is not feasible. Innovative applications for the treatment of gastrointestinal bleeding and management of benign refractory esophageal strictures have also been reported. Endoscopic cryotherapy represents a safe, effective, and well tolerated therapeutic option for various clinical scenarios in gastrointestinal endoscopy, including challenging disease states such as refractory Barrett's esophagus and advanced esophageal cancer. Advancements in cryotherapy technology and ongoing research continue to explore additional clinical indications and expand the role of endoscopic cryotherapy in patient care with an aim toward improved patient outcomes.

Identifiants

DOI: 10.1097/MOG.0000000000001040 PMID: 38662539

pubmed: 38662539

doi: 10.1097/MOG.0000000000001040

pii: 00001574-990000000-00148

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Eluri S, Cotton CC, Kaul V, et al. Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett's esophagus: results from a multicenter prospective registry. Gastrointest Endosc 2024; S0016-5107(24)00042-7. doi:10.1016/j.gie.2024.01.023. Epub ahead of print. PMID: 38272279.

doi: 10.1016/j.gie.2024.01.023.

Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology 2014; 68:1–11.

Greenwald BD, Dumot JA, Abrams JA, et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc 2010; 71:686–693.

Dhaliwal A, Saghir SM, Mashiana HS, et al. Endoscopic cryotherapy: indications, techniques, and outcomes involving the gastrointestinal tract. World J Gastrointest Endosc 2022; 14:17–28.

Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG Guideline. Am J Gastroenterol 2022; 117:559–587.

Johnston MH, Eastone JA, Horwhat JD, et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 2005; 62:842–848.

Dumot JA, Vargo JJ 2nd, Falk GW, et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 2009; 70:635–644.

Ghorbani S, Tsai FC, Greenwald BD, et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry. Dis Esophagus 2016; 29:241–247.

Gosain S, Mercer K, Twaddell WS, et al. Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc Aug 2013; 78:260–265.

Ramay FH, Cui Q, Greenwald BD. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up. Gastrointest Endosc 2017; 86:626–632.

Scholvinck DW, Kunzli HT, Kestens C, et al. Treatment of Barrett's esophagus with a novel focal cryoablation device: a safety and feasibility study. Endoscopy 2015; 47:1106–1112.

Canto MI, Shin EJ, Khashab MA, et al. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus. Endoscopy 2015; 47:591.

Kunzli HT, Scholvinck DW, Meijer SL, et al. Efficacy of the CryoBalloon Focal Ablation System for the eradication of dysplastic Barrett's esophagus islands. Endoscopy 2017; 49:169–175.

Castela J, Demedts I, Bisschops R. Treatment of low grade dysplasia in Barrett's esophagus with a new-generation cryoballoon device. Endoscopy 2018; 50:E318–E319.

Canto MI, Trindade AJ, Abrams J, et al. Multifocal cryoballoon ablation for eradication of Barrett's esophagus-related neoplasia: a prospective multicenter clinical trial. Am J Gastroenterol 2020; 115:1879–1890.

Sengupta N, Ketwaroo GA, Bak DM, et al. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective. Gastrointest Endosc 2015; 82:443–448.

Visrodia K, Zakko L, Singh S, et al. Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc 2018; 87:1396–1404. e1.

Solomon SS, Kothari S, Smallfield GB, et al. Liquid nitrogen spray cryotherapy is associated with less postprocedural pain than radiofrequency ablation in Barrett's esophagus: a multicenter prospective study. J Clin Gastroenterol 2019; 53:e84–e90.

Costamagna G, Shah SK, Tringali A, et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc 2003; 17:891–895.

Choi SJ, Kim JH, Choi JW, et al. Fully covered, retrievable self-expanding metal stents (Niti-S) in palliation of malignant dysphagia: long-term results of a prospective study. Scand J Gastroenterol 2011; 46:875–880.

Kachaamy T, Prakash R, Kundranda M, et al. Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer. Gastrointest Endosc 2018; 88:447–455.

Greenwald BD, Dumot JA, Horwhat JD, et al. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus 2010; 23:13–19.

Gopakumar H, Khan H, Sharma N, Puli SR. Endoscopic spray cryotherapy for dysphagia palliation in esophageal cancer: systematic review and meta-analysis. Endosc Int Open 2024; 12:E211–E217.

Eluri S, Kaul V, Sharma N. Palliative endoscopic spray cryotherapy to prevent worsening of dysphagia and improve quality of life in esophageal cancer. J Clin Oncol 2021; 39: (3 suppl): 219.

Kachaamy T, Sharma N, Shah T, et al. A prospective multicenter study to evaluate the impact of cryotherapy on dysphagia and quality of life in patients with inoperable esophageal cancer. Endoscopy 2023; 55:889–897.

Cash BD, Johnston LR, Johnston MH. Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol 2007; 5:34.

Canto MI, Abrams JA, Kunzli HT, et al. Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video). Gastrointest Endosc 2018; 87:574–581.

Bi D, Alghamdi S, Brewer Gutierrez OI. Cryotherapy for the treatment of benign refractory rectal bleeding. Endoscopy 2023; 55:E368–E369.

Cho S, Zanati S, Yong E, et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc 2008; 68:895–902.

Kantsevoy SV, Cruz-Correa MR, Vaughn CA, et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc 2003; 57:403–406.

Patel AA, Trindade AJ, Diehl DL, et al. Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia. United European Gastroenterol J 2018; 6:1155–1160.

Trindade AJ, Inamdar S, Sejpal DV. Nitrous oxide CryoBalloon therapy of refractory gastric antral vascular ectasia. Endoscopy 2017; 49:923–924.

Hou JK, Abudayyeh S, Shaib Y. Treatment of chronic radiation proctitis with cryoablation. Gastrointest Endosc 2011; 73:383–389.

Moawad FJ, Maydonovitch CL, Horwhat JD. Efficacy of cryospray ablation for the treatment of chronic radiation proctitis in a pilot study. Dig Endosc 2013; 25:174–179.

Nasir AB, Bouvette C, Rumman A. Safety and effectiveness of liquid nitrogen spray cryotherapy-assisted balloon dilation of refractory anastomotic strictures. Gastrointest Endosc 2023; 97:AB341–AB342.

Roccato M, Duh E, Mai D, et al. CryoDilation: a novel treatment for benign esophageal strictures using liquid nitrogen spray cryotherapy. Am J Gastroenterol 2019; 114:S1025.

Raphael KL, Benias PC, Trindade AJ. Salvage CryoBalloon cryotherapy ablation for a duodenal adenoma. Endoscopy 2020; 52:E189–E190.

Dbouk M, Brewer Guiterrez O, Trindade AJ, et al. Initial multicenter experience with nitrous oxide cryoballoon for treatment of flat duodenal adenomas (with video). Gastrointest Endosc 2021; 93:240–246.

Shaheen NJ, Greenwald BD, Peery AF, et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010; 71:680–685.

Canto MI, Shaheen NJ, Almario JA, et al. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video). Gastrointest Endosc 2018; 88:438–446. e2.

Westerveld DR, Nguyen K, Banerjee D, et al. Safety and effectiveness of balloon cryoablation for treatment of Barrett's associated neoplasia: systematic review and meta-analysis. Endosc Int Open 2020; 8:E172–E178.